These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25353315)

  • 21. Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.
    Wang JF; Chou KC
    Protein Eng Des Sel; 2010 Aug; 23(8):663-6. PubMed ID: 20571121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding hot spots and amantadine orientation in the influenza a virus M2 proton channel.
    Chuang GY; Kozakov D; Brenke R; Beglov D; Guarnieri F; Vajda S
    Biophys J; 2009 Nov; 97(10):2846-53. PubMed ID: 19917240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation and proton transport mechanism in influenza A M2 channel.
    Wei C; Pohorille A
    Biophys J; 2013 Nov; 105(9):2036-45. PubMed ID: 24209848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Gomez LM; Fegley B; Mulcahy ER; Hill MS; Culley N; Pinson DM; Nothnick W; Powers MF; Wong SW; Stephens EB
    Virology; 2006 Jan; 344(2):541-59. PubMed ID: 16199074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. XFEL structures of the influenza M2 proton channel: Room temperature water networks and insights into proton conduction.
    Thomaston JL; Woldeyes RA; Nakane T; Yamashita A; Tanaka T; Koiwai K; Brewster AS; Barad BA; Chen Y; Lemmin T; Uervirojnangkoorn M; Arima T; Kobayashi J; Masuda T; Suzuki M; Sugahara M; Sauter NK; Tanaka R; Nureki O; Tono K; Joti Y; Nango E; Iwata S; Yumoto F; Fraser JS; DeGrado WF
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13357-13362. PubMed ID: 28835537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpreting Thermodynamic Profiles of Aminoadamantane Compounds Inhibiting the M2 Proton Channel of Influenza A by Free Energy Calculations.
    Homeyer N; Ioannidis H; Kolarov F; Gauglitz G; Zikos C; Kolocouris A; Gohlke H
    J Chem Inf Model; 2016 Jan; 56(1):110-26. PubMed ID: 26690735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for proton conduction and inhibition by the influenza M2 protein.
    Hong M; DeGrado WF
    Protein Sci; 2012 Nov; 21(11):1620-33. PubMed ID: 23001990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
    Intharathep P; Laohpongspaisan C; Rungrotmongkol T; Loisruangsin A; Malaisree M; Decha P; Aruksakunwong O; Chuenpennit K; Kaiyawet N; Sompornpisut P; Pianwanit S; Hannongbua S
    J Mol Graph Model; 2008 Oct; 27(3):342-8. PubMed ID: 18620883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.
    Du QS; Huang RB; Wang CH; Li XM; Chou KC
    J Theor Biol; 2009 Jul; 259(1):159-64. PubMed ID: 19285514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extension of the free energy workflow FEW towards implicit solvent/implicit membrane MM-PBSA calculations.
    Homeyer N; Gohlke H
    Biochim Biophys Acta; 2015 May; 1850(5):972-982. PubMed ID: 25450172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of Broad-Spectrum Inhibitors of Influenza A Virus M2 Proton Channels: A Molecular Modeling Approach.
    Klimochkin YN; Shiryaev VA; Petrov PV; Radchenko EV; Palyulin VA; Zefirov NS
    Curr Comput Aided Drug Des; 2016; 12(2):154-64. PubMed ID: 27146707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus.
    Huang RB; Du QS; Wang CH; Chou KC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1243-7. PubMed ID: 18996090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational and experimental analysis of drug binding to the Influenza M2 channel.
    Alhadeff R; Assa D; Astrahan P; Krugliak M; Arkin IT
    Biochim Biophys Acta; 2014 Apr; 1838(4):1068-73. PubMed ID: 24016551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dimer is the minimal proton-conducting unit of the influenza a virus M2 channel.
    Kawano K; Yano Y; Matsuzaki K
    J Mol Biol; 2014 Jul; 426(14):2679-91. PubMed ID: 24816000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influenza A virus M2 channel: a molecular modeling and simulation study.
    Sansom MS; Kerr ID; Smith GR; Son HS
    Virology; 1997 Jun; 233(1):163-73. PubMed ID: 9201226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Perturbation Effects Exerted by the Influenza A M2 WT Protein Inhibitors Amantadine and the Spiro[pyrrolidine-2,2'-adamantane] Variant AK13 to Membrane Bilayers Studied Using Biophysical Experiments and Molecular Dynamics Simulations.
    Konstantinidi A; Naziris N; Chountoulesi M; Kiriakidi S; Sartori B; Kolokouris D; Amentisch H; Mali G; Ntountaniotis D; Demetzos C; Mavromoustakos T; Kolocouris A
    J Phys Chem B; 2018 Nov; 122(43):9877-9895. PubMed ID: 30285441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding and Proton Blockage by Amantadine Variants of the Influenza M2
    Tzitzoglaki C; Wright A; Freudenberger K; Hoffmann A; Tietjen I; Stylianakis I; Kolarov F; Fedida D; Schmidtke M; Gauglitz G; Cross TA; Kolocouris A
    J Med Chem; 2017 Mar; 60(5):1716-1733. PubMed ID: 28107633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiscale Simulation of an Influenza A M2 Channel Mutant Reveals Key Features of Its Markedly Different Proton Transport Behavior.
    Watkins LC; DeGrado WF; Voth GA
    J Am Chem Soc; 2022 Jan; 144(2):769-776. PubMed ID: 34985907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influenza m2 cytoplasmic tail changes the proton-exchange equilibria and the backbone conformation of the transmembrane histidine residue to facilitate proton conduction.
    Liao SY; Yang Y; Tietze D; Hong M
    J Am Chem Soc; 2015 May; 137(18):6067-77. PubMed ID: 25892574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel.
    Arns S; Balgi AD; Shimizu Y; Pfeifer TA; Kumar N; Shidmoossavee FS; Sun S; Tai SS; Agafitei O; Jaquith JB; Bourque E; Niikura M; Roberge M
    Eur J Med Chem; 2016 Sep; 120():64-73. PubMed ID: 27187859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.